
Sign up to save your podcasts
Or


Medication nonadherence is not new, but it remains a persistent, complex problem. Adherence rates hover near 50%—roughly the same as two decades ago—as companies explore new ways to engage patients and help them stick to treatment regimens.
AdhereHealth combines technology with care navigators to identify at-risk patients and help them consistently access their prescriptions.
In this episode of "Podnosis," Fierce Healthcare Senior Writer Anastassia Gliadkovskaya speaks with Chandra Y. Osborn, Ph.D., M.P.H., chief experience officer at AdhereHealth, about how the company takes on risk to drive outcomes and why it keeps a human in the loop.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.
By Fierce Healthcare4.7
33 ratings
Medication nonadherence is not new, but it remains a persistent, complex problem. Adherence rates hover near 50%—roughly the same as two decades ago—as companies explore new ways to engage patients and help them stick to treatment regimens.
AdhereHealth combines technology with care navigators to identify at-risk patients and help them consistently access their prescriptions.
In this episode of "Podnosis," Fierce Healthcare Senior Writer Anastassia Gliadkovskaya speaks with Chandra Y. Osborn, Ph.D., M.P.H., chief experience officer at AdhereHealth, about how the company takes on risk to drive outcomes and why it keeps a human in the loop.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.

4,887 Listeners

4,363 Listeners

1,097 Listeners

30,240 Listeners

2,383 Listeners

346 Listeners

56,599 Listeners

225 Listeners

497 Listeners

9,533 Listeners

340 Listeners

203 Listeners

388 Listeners

692 Listeners

173 Listeners